EUS-guided liver biopsy provides diagnostic samples comparable with those via the percutaneous or transjugular route

Pineda, Jonh; Diehl, David L.; Miao, Chuan L.; Johal, Amitpal S.; Khara, Harshit S.; Bhanushali, Ashok; Chen, Eric Z.

doi:10.1016/j.gie.2015.08.025

Cited by 109 publications

(95 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Adverse events were uncommon (1.8%), and included abdominal pain and selflimited hematoma. 75 The superiority of the Sharkcore needle in obtaining CPTs over the 19-gauge Procore, standard 19-gauge needles, and two different percutaneous 18-gauge needles has been reported in an animal study by Schulman et al 78 Moreover, in another recent study by Pineda et al, 79 EUS-LB using a 19gauge FNA needle of both lobes produced significantly more tissue in term of both TSL and CPTs as compared with both percutaneous needles and those utilized for the transjugular route.…”

Section: Eus For the Evaluation Of Parenchymal Liver Diseasesmentioning

confidence: 90%

Endoscopic Ultrasound for the Hepatologist: A Comprehensive Review

et al. 2018

View full text Add to dashboard Cite

In the last few years, the diagnostic and therapeutic utilization of endoscopic ultrasound (EUS) for a variety of liver conditions has exponentially grown. We performed a thorough search for all available studies on the performance of diagnostic and therapeutic EUS in the field of hepatology. This article reviews the indication of EUS in the evaluation and treatment of portal hypertension, portal vein pressure measurement, focal liver lesions, and parenchymal liver diseases, and presents all the clinical evidences available so far in this regard. All the review data suggest that EUS is becoming an increasingly important tool in the armamentarium of the hepatologists for the management of certain liver-related conditions. Implementation in the education of the hepatologists of means to become more familiar with both diagnostic and therapeutic capabilities of EUS is warranted.

show abstract

Section: Eus For the Evaluation Of Parenchymal Liver Diseasesmentioning

confidence: 90%

Endoscopic Ultrasound for the Hepatologist: A Comprehensive Review

et al. 2018

View full text Add to dashboard Cite

show abstract

“…The first report was by Mathew in 2005 for two patients who underwent either EUS or endoscopic retrograde pancreaticography (ERCP) for evaluation of abnormal liver enzymes . Since then, multiple studies have shown the efficacy of EUS‐guided liver biopsy with specimens showing diagnostic yield of 90–100% and a low rate of adverse events . Comparisons between the total specimen length and number of complete portal triads in the literature to date can be found in Table .…”

Section: Eus‐guided Liver Biopsymentioning

confidence: 99%

“…Although there are no defined criteria for adequacy for specimens obtained by EUS, the majority of these biopsies appear to be adequate as defined by the American Association for the Study of Liver Disease (AASLD) guidelines with a total specimen length greater than 30 mm and number of complete portal triads greater than 11 . EUS‐guided biopsies have also been shown to be non‐inferior to those obtained by percutaneous and transjugular routes . These biopsies also have been shown to be accurate in the staging of fibrosis when compared to magnetic resonance elastography .…”

Section: Eus‐guided Liver Biopsymentioning

confidence: 99%

Endoscopic ultrasound and the liver: current applications and beyond

Shah

Baron

2018

J Hepato Biliary Pancreat

View full text Add to dashboard Cite

The diagnosis and management of many gastrointestinal conditions has been augmented by the development of endoscopic ultrasound. Its role in the diagnosis and management of liver disease has been somewhat limited, but with the rapid development of therapeutic advancements it has quickly emerged as a useful tool in the management of complex hepatic conditions. This includes its use in the management of complications of portal hypertension as well as its use in liver lesions and cancer. In this paper, we review case studies, case series and trials for hepatic applications of endoscopic ultrasound to provide an overview of its utilization in this field and demonstrating its more novel applications for future use.

show abstract

“…Studies have demonstrated a high technical success and adequacy of tissue yield (> 98%) with EUS-LB that are comparable to the percutaneous or transjugular routes. 12,16,17 In a recently published meta-analysis including 9 studies (437 patients) the pooled rate of histological diagnosis was 93.9% (95% confidence interval [CI] = 84.9-97.7, heterogeneity [I 2 ] = 75.3%). 18 Despite the high yield the rates of adverse events remain low.…”

mentioning

confidence: 99%